Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Almac Diagnostics Ltd Company Overview 5
Almac Diagnostics Ltd Company Snapshot 5
Almac Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Almac Diagnostics Ltd – Pipeline Analysis Overview 8
Almac Diagnostics Ltd – Key Facts 8
Almac Diagnostics Ltd – Major Products and Services 9
Almac Diagnostics Ltd Pipeline Products by Development Stage 10
Almac Diagnostics Ltd Pipeline Products Overview 12
2-Gene qPCR LDT 12
2-Gene qPCR LDT Product Overview 12
ALM AADx Assay 13
ALM AADx Assay Product Overview 13
Angiogenesis Subtype Diagnostic Assay 14
Angiogenesis Subtype Diagnostic Assay Product Overview 14
Diagnostic Test – Ovarian Cancer 15
Diagnostic Test – Ovarian Cancer Product Overview 15
DNA Damage Response Deficiency Assay – Breast Cancer 16
DNA Damage Response Deficiency Assay – Breast Cancer Product Overview 16
DNA Damage Response Deficiency Assay – Colorectal Cancer 17
DNA Damage Response Deficiency Assay – Colorectal Cancer Product Overview 17
DNA Damage Response Deficiency Assay – Esophageal Cancer 18
DNA Damage Response Deficiency Assay – Esophageal Cancer Product Overview 18
DNA Damage Response Deficiency Assay – Ovarian Cancer 19
DNA Damage Response Deficiency Assay – Ovarian Cancer Product Overview 19
NanoStrings’s nCounter Dx Analysis System with FLEX – Companion Diagnostic Assay 20
NanoStrings’s nCounter Dx Analysis System with FLEX – Companion Diagnostic Assay Product Overview 20
Next-Generation Sequencing Based Companion Diagnostic Assay 21
Next-Generation Sequencing Based Companion Diagnostic Assay Product Overview 21
Prognostic Test – Early Stage Lung Cancer 22
Prognostic Test – Early Stage Lung Cancer Product Overview 22
Prognostic Test – NSCLC 23
Prognostic Test – NSCLC Product Overview 23
Prostate Cancer Metastatic Assay 24
Prostate Cancer Metastatic Assay Product Overview 24
RSPO3 CLIA Assay 25
RSPO3 CLIA Assay Product Overview 25
Almac Diagnostics Ltd – Key Competitors 26
Almac Diagnostics Ltd – Key Employees 27
Almac Diagnostics Ltd – Locations And Subsidiaries 28
Head Office 28
Recent Developments 29
Almac Diagnostics Ltd, Recent Developments 29
Oct 23, 2017: Queens University Belfast Leads Largest Study of its Kind to Transform Prostate Cancer Treatment 29
Jun 13, 2017: Almac Group Awarded U.S. Patents for Ground-breaking “DDRD” Assay 29
Apr 20, 2017: Almac Group Announces Publication of Prostate Cancer Metastatic Assay Validation 30
Feb 16, 2017: Almac Diagnostics Appoints Dr Leeona Galligan as Vice President UK Operations 30
Jul 07, 2015: Almac Group Appoints Dr. John Robson as VP Quality Operations 31
Aug 14, 2014: Almac Group Announces 348 New Jobs in £54m Investment 31
Nov 30, 2011: Almac’s Diagnostic Laboratory Receives Accreditation From College Of American Pathologists 32
Mar 30, 2011: Almac Open CLIA Lab For Biomarker Clinical Trials 32
Jul 31, 2008: Almac To Develop Prognostic Test For Early Non Small Cell Lung Cancer Announce World’s Largest Gene Expression Study 32
Appendix 34
Methodology 34
About GlobalData 36
Contact Us 36
Disclaimer 37
Almac Diagnostics Ltd Pipeline Products and Ongoing Clinical Trials Overview 5
Almac Diagnostics Ltd Pipeline Products by Equipment Type 6
Almac Diagnostics Ltd Pipeline Products by Indication 7
Almac Diagnostics Ltd, Key Facts 8
Almac Diagnostics Ltd, Major Products and Services 9
Almac Diagnostics Ltd Number of Pipeline Products by Development Stage 10
Almac Diagnostics Ltd Pipeline Products Summary by Development Stage 11
2-Gene qPCR LDT - Product Status 12
2-Gene qPCR LDT - Product Description 12
ALM AADx Assay - Product Status 13
ALM AADx Assay - Product Description 13
Angiogenesis Subtype Diagnostic Assay - Product Status 14
Angiogenesis Subtype Diagnostic Assay - Product Description 14
Diagnostic Test - Ovarian Cancer - Product Status 15
Diagnostic Test - Ovarian Cancer - Product Description 15
DNA Damage Response Deficiency Assay - Breast Cancer - Product Status 16
DNA Damage Response Deficiency Assay - Breast Cancer - Product Description 16
DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Status 17
DNA Damage Response Deficiency Assay - Colorectal Cancer - Product Description 17
DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Status 18
DNA Damage Response Deficiency Assay - Esophageal Cancer - Product Description 18
DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Status 19
DNA Damage Response Deficiency Assay - Ovarian Cancer - Product Description 19
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Status 20
NanoStrings’s nCounter Dx Analysis System with FLEX - Companion Diagnostic Assay - Product Description 20
Next-Generation Sequencing Based Companion Diagnostic Assay - Product Status 21
Next-Generation Sequencing Based Companion Diagnostic Assay - Product Description 21
Prognostic Test - Early Stage Lung Cancer - Product Status 22
Prognostic Test - Early Stage Lung Cancer - Product Description 22
Prognostic Test - NSCLC - Product Status 23
Prognostic Test - NSCLC - Product Description 23
Prostate Cancer Metastatic Assay - Product Status 24
Prostate Cancer Metastatic Assay - Product Description 24
RSPO3 CLIA Assay - Product Status 25
RSPO3 CLIA Assay - Product Description 25
Almac Diagnostics Ltd, Key Employees 27
Glossary 35